Layoffs
Filter News
Found 187 articles
-
There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.
-
Since GSK initiated this new focus, the company has made several key moves to support the plan, including the December 2018 acquisition of Tesaro Oncology.
-
The loss of patent protection on two drugs is forcing Gilead Sciences to terminate about 20 percent of its sales team, according to reports.
-
The Pennsylvania-based company disagrees with the FDA's analysis of its clinical data and will seek to work with the agency for approval.
-
The latest job cuts at Merrimack come about five months after the company culled 60 percent of its staff.
-
More job cuts are coming to California life science companies. Charles River Labs and Janssen are both making cuts as they reprioritize their businesses, according to Worker Adjustment and Retraining Notifications filed with the state of California.
-
The South San Francisco cuts are not surprising, given that in December the company was forced to halt a Phase III study of Rova-T.
-
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know if you've updated your resume and components that make it competitive.
-
Scott Gottlieb, the proactive commissioner of the U.S. Food and Drug Administration has resigned, according to reports. Gottlieb will leave the regulatory agency in about a month.
-
If you’re in the pharma or biotech industry and are looking for work, multiple companies have announced expansions of their employee pool over the past few days. BioSpace rounds up a few of the announcements.
-
January was a rough month for many pharma employees in California, as several companies pulled the trigger on layoffs, or announced coming layoffs that will affect hundreds of employees.
-
As Britain’s plans to leave the European Union—Brexit—stagger toward the March 29 deadline, the UK biopharma industry is taking stock of the likely impact.
-
First reported by the San Antonio Business Journal, the company will cut about 265 employees, 200 from its Alamo City site and the rest from its Charlotte facility. The cuts are part of a restructuring and will be handled over time, rather than all in one fell swoop of pink slips.
-
When biotech companies post openings for new positions, hiring managers often face the immense task of sorting through numerous resumes of qualified candidates. However, in South Korea, hiring managers are facing a different problem – a dearth of qualified candidates.
-
BioSpace Movers and Shakers: Feb. 8
2/8/2019
In this week's edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles. -
Mesothelioma Compensation Center Now Appeals to a Navy Submarine Veteran with Mesothelioma or Asbestos Exposure Lung Cancer to Not Shortchange Themselves and To Call for Direct Access to Erik Karst for a Better Compensation Result
2/6/2019
The Mesothelioma Compensation Center is the top ranked source in the nation for the best possible financial compensation results for a Navy Veteran with mesothelioma or asbestos exposure lung cancer because of exposure to asbestos on a nuclear submarine
-
According to WARN notices, the two companies will slash a total of 106 jobs starting in March.
-
Despite the significant amount of finances invested in the Bay Area biotech environment, December and January saw a significant number of job cuts.
-
Singapore-based ASLAN slashed 30 percent of its staff following a recent mid-stage failure, and California-based Aduro has cut 37 percent of employees.
-
Vertex fired Chief Operating Officer Ian Smith, who had also been serving as interim chief financial officer since December. The Boston-based company said it promptly launched a comprehensive investigation into the allegations made against Smith with the assistance of an independent external coun...